University of Michigan

University / College


Location: Ann Arbor, MI, United States (USA) (US) US

ISNI: 0000000086837370

ROR: https://ror.org/00jmfr291

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Nanoscale deformation mechanics reveal resilience in nacre of Pinna nobilis shell (2019) Gim J, Schnitzer N, Otter LM, Cui Y, Motreuil S, Marin F, Wolf S, et al. Journal article Maxi J1820+070 with Nustar I. An increase in variability frequency but a stable reflection spectrum: Coronal properties and implications for the inner disc in black hole binaries (2019) Buisson DJK, Fabian AC, Barret D, Furst F, Gandhi P, Garcia J, Kara E, et al. Journal article The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease (2019) Srinagesh H, Ozbek U, Kapoor U, Ayuk FA, Aziz MD, Ben-David K, Choe HK, et al. Conference contribution Beam-helicity asymmetries for single-hadron production in semi-inclusive deep-inelastic scattering from unpolarized hydrogen and deuterium targets (2019) Airapetian A, Akopov N, Akopov Z, Aschenauer EC, Augustyniak W, Belostotski S, Blok HP, et al. Journal article Predictors of Delayed Response to Tofacitinib: Results of the OCTAVE Open Study for Delayed Responders (2019) Regueiro M, Kinnucan JA, Ungaro R, Quirk D, Su C, Lawendy N, Fan H, et al. Conference contribution Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial (2019) Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Conference contribution The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases (2019) Matteson E, Kelly C, Distler J, Mann-Vold AMH, Seibold J, Mittoo S, Distler O, et al. Conference contribution Delineating the clinical spectrum due to heterozygous TRAF7 missense mutations: A series of 38 cases (2019) Amiel J, Mishra K, Castilla L, Selmer KK, Barak T, Yang S, Blanco-Sanchez B, et al. Conference contribution Observations of the Ultra-compact X-Ray Binary 4U 1543-624 in Outburst with NICER, INTEGRAL, Swift, and ATCA (2019) Ludlam RM, Shishkovsky L, Bult PM, Miller JM, Zoghbi A, Strohmayer TE, Reynolds M, et al. Journal article Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article